Skip to main content
SpringerLink
Log in
Book cover

Acquired Neuromuscular Disorders pp 275–284Cite as

Toxic Neuropathies

  • Chapter
  • First Online:

  • 1213 Accesses

Abstract

Several toxic agents have an easy access to the peripheral nervous system. These toxic substances belong to different classes, including therapeutic drugs, recreational abuse substances, and environmental and industrial contaminants.

Establishment of a real causal relationship between peripheral nervous system damage and toxic agents exposure is obvious in some condition (e. g., in the course of anticancer chemotherapy), but it can be very difficult or even misleading in other contexts, when potential exposure is not easy to be proven or is not reported by the affected subjects.

Not all the reports describing the peripheral toxicity of substances causing rare events are convincing, and the list of putative neurotoxic agents is probably overestimated. Nevertheless, relationship even with agents with only occasional neurotoxicity has been clearly established.

The clinical effects of the exposure to neurotoxic agents are highly variable, depending on the mechanism of their action and on the intracellular target. In most cases sensory impairment is exclusive or largely predominant over motor or autonomic damage. Similarly, the clinical course may be acute, subacute, or chronic, and recovery after withdrawal from toxic exposure is not always guaranteed. Moreover, worsening lasting months after the suspension of toxic exposure (the “coasting effect”) has also been reported.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   99.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   129.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Weimer LH, Sachdev N (2009) Update on medication-induced peripheral neuropathy. Curr Neurol Neurosci Rep 9:69–75

    Article  CAS  PubMed  Google Scholar 

  2. Arezzo JC, Litwak MS, Zotova EG (2011) Correlation and dissociation of electrophysiology and histopathology in the assessment of toxic neuropathy. Toxicol Pathol 39:46–51

    Article  PubMed  Google Scholar 

  3. DeGrandchamp RL, Lowndes HE (1990) Early degeneration and sprouting at the rat neuromuscular junction following acrylamide administration. Neuropathol Appl Neurobiol 16:239–254

    Article  CAS  PubMed  Google Scholar 

  4. Marmiroli P, Nicolini G, Miloso M, Scuteri A, Cavaletti G (2012) The fundamental role of morphology in experimental neurotoxicology: the example of chemotherapy-induced peripheral neurotoxicity. Ital J Anat Embryol 117:75–97

    PubMed  Google Scholar 

  5. Grisold W, Cavaletti G, Windebank AJ (2012) Peripheral neuropathies from chemotherapeutics and targeted agents: diagnosis, treatment, and prevention. Neuro Oncol 14(Suppl 4):iv45–iv54

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Cavaletti G, Alberti P, Marmiroli P (2011) Chemotherapy-induced peripheral neurotoxicity in the era of pharmacogenomics. Lancet Oncol 12:1151–1161

    Article  CAS  PubMed  Google Scholar 

  7. Cavaletti G, Marmiroli P (2010) Chemotherapy-induced peripheral neurotoxicity. Nat Rev Neurol 6:657–666

    Article  PubMed  Google Scholar 

  8. Carozzi VA, Chiorazzi A, Canta A, Meregalli C, Oggioni N, Cavaletti G, Marmiroli P (2015) Chemotherapy-induced peripheral neurotoxicity in immune-deficient mice: new useful ready-to-use animal models. Exp Neurol 264:92–102

    Article  CAS  PubMed  Google Scholar 

  9. Carozzi VA, Canta A, Oggioni N, Sala B, Chiorazzi A, Meregalli C, Bossi M, Marmiroli P, Cavaletti G (2010) Neurophysiological and neuropathological characterization of new murine models of chemotherapy-induced chronic peripheral neuropathies. Exp Neurol 226:301–309

    Article  CAS  PubMed  Google Scholar 

  10. Bennett GJ, Doyle T, Salvemini D (2014) Mitotoxicity in distal symmetrical sensory peripheral neuropathies. Nat Rev Neurol 10:326–336

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Meregalli C, Chiorazzi A, Carozzi VA, Canta A, Sala B, Colombo M, Oggioni N, Ceresa C, Foudah D, La Russa F, Miloso M, Nicolini G, Marmiroli P, Bennett DL, Cavaletti G (2014) Evaluation of tubulin polymerization and chronic inhibition of proteasome as cytotoxicity mechanisms in bortezomib-induced peripheral neuropathy. Cell Cycle 13:612–621

    Article  CAS  PubMed  Google Scholar 

  12. Cavaletti G, Ceresa C, Nicolini G, Marmiroli P (2014) Neuronal drug transporters in platinum drugs-induced peripheral neurotoxicity. Anticancer Res 34:483–486

    CAS  PubMed  Google Scholar 

  13. Sprowl JA, Ciarimboli G, Lancaster CS, Giovinazzo H, Gibson AA, Du G, Janke LJ, Cavaletti G, Shields AF, Sparreboom A (2013) Oxaliplatin-induced neurotoxicity is dependent on the organic cation transporter oct2. Proc Natl Acad Sci U S A 110:11199–11204

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Sprowl JA, Lancaster CS, Pabla N, Hermann E, Kosloske AM, Gibson AA, Li L, Zeeh D, Schlatter E, Janke LJ, Ciarimboli G, Sparreboom A (2014) Cisplatin-induced renal injury is independently mediated by oct2 and p53. Clin Cancer Res 20:4026–4035

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Abbi KK, Rizvi SM, Sivik J, Thyagarajan S, Loughran T, Drabick JJ (2010) Guillain-Barré syndrome after use of alemtuzumab (Campath) in a patient with t-cell prolymphocytic leukemia: a case report and review of the literature. Leuk Res 34:e154–e156

    Article  PubMed  Google Scholar 

  16. Pastorelli F, Derenzini E, Plasmati R, Pellegrini C, Broccoli A, Casadei B, Argnani L, Salvi F, Pileri S, Zinzani PL (2013) Severe peripheral motor neuropathy in a patient with hodgkin lymphoma treated with brentuximab vedotin. Leuk Lymphoma 54:2318–2321

    Article  PubMed  Google Scholar 

  17. Orr CF, Ahlskog JE (2009) Frequency, characteristics, and risk factors for amiodarone neurotoxicity. Arch Neurol 66:865–869

    Article  PubMed  Google Scholar 

  18. Hao S (2013) The molecular and pharmacological mechanisms of HIV-related neuropathic pain. Curr Neuropharmacol 11:499–512

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Manji H (2011) Toxic neuropathy. Curr Opin Neurol 24:484–490

    Article  CAS  PubMed  Google Scholar 

  20. Mellion M, Gilchrist JM, de la Monte S (2011) Alcohol-related peripheral neuropathy: nutritional, toxic, or both? Muscle Nerve 43:309–316

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Koike H, Iijima M, Sugiura M, Mori K, Hattori N, Ito H, Hirayama M, Sobue G (2003) Alcoholic neuropathy is clinicopathologically distinct from thiamine-deficiency neuropathy. Ann Neurol 54:19–29

    Article  PubMed  Google Scholar 

  22. Ramcharan K, Ramesar A, Ramdath M, Teelucksingh J, Gosein M (2014) Encephalopathy and neuropathy due to glue, paint thinner, and gasoline sniffing in trinidad and tobago-MRI findings. Case Rep Neurol Med 2014:850109

    PubMed  PubMed Central  Google Scholar 

  23. Sills RC, Harry GJ, Morgan DL, Valentine WM, Graham DG (1998) Carbon disulfide neurotoxicity in rats: V. Morphology of axonal swelling in the muscular branch of the posterior tibial nerve and spinal cord. Neurotoxicology 19:117–127

    CAS  PubMed  Google Scholar 

  24. Ghosh A (2013) Evaluation of chronic arsenic poisoning due to consumption of contaminated ground water in west Bengal, India. Int J Prev Med 4:976–979

    PubMed  PubMed Central  Google Scholar 

  25. Kim S, Takeuchi A, Kawasumi Y, Endo Y, Lee H, Kim Y (2012) A Guillain-Barré syndrome-like neuropathy associated with arsenic exposure. J Occup Health 54:344–347

    Article  CAS  PubMed  Google Scholar 

  26. Rice KM, Walker EM, Wu M, Gillette C, Blough ER (2014) Environmental mercury and its toxic effects. J Prev Med Public Health 47:74–83

    Article  PubMed  PubMed Central  Google Scholar 

  27. Kingman A, Albers JW, Arezzo JC, Garabrant DH, Michalek JE (2005) Amalgam exposure and neurological function. Neurotoxicology 26:241–255

    Article  CAS  PubMed  Google Scholar 

  28. Thomson RM, Parry GJ (2006) Neuropathies associated with excessive exposure to lead. Muscle Nerve 33:732–741

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. School of Medicine and Surgery, University of Milano-Bicocca, Via Cadore 48, Monza, 20900, Italy

    Guido Cavaletti & Paola Marmiroli

Authors
  1. Guido Cavaletti
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Paola Marmiroli
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Guido Cavaletti .

Editor information

Editors and Affiliations

  1. Neuromuscular Center, IRCCS Fondazione San Camillo Hospit, Venice, Italy

    Corrado Angelini

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Cavaletti, G., Marmiroli, P. (2016). Toxic Neuropathies. In: Angelini, C. (eds) Acquired Neuromuscular Disorders. Springer, Cham. https://doi.org/10.1007/978-3-319-29514-5_20

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-29514-5_20

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-29512-1

  • Online ISBN: 978-3-319-29514-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation